Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Elutia Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 24 | 22 | −2 |
| Shares | 6.89M | 5.69M | −1.20M (−17.4%) |
| Value | $14.9M | $17.9M | +$3.04M (+20.5%) |
New holders (2)
Institutions that held Elutia Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverarc Capital Management, LLC | 78,580 | $247.5K | 0.07% |
| Federated Hermes, Inc. | 342 | $1.08K | 0.00% |
Sold out (4)
Institutions that held Elutia Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Worth Venture Partners, LLC | 478,542 | $1.03M |
| Indie Asset Partners, LLC | 30,000 | $64.8K |
| XTX Topco Ltd | 11,380 | $24.6K |
| Virtu Financial LLC | 11,328 | $24.0K |